Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
Notice of June 2, 2020 Lead Plaintiff Deadline for Shareholders in the Gossamer Bio, Inc. Securities Class Action Lawsuit
01:00pm, Tuesday, 26'th May 2020
Robbins Geller Rudman & Dowd LLP announces that purchasers of Gossamer Bio, Inc. (NASDAQ:GOSS) common stock between February 8, 2019 and December 13, 2019 (the "Class Period"), including acquirers of
CLASS ACTION UPDATE for MESA, GOSS and BIDU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
07:20pm, Monday, 25'th May 2020
NEW YORK, NY / ACCESSWIRE / May 25, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders
Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering in February 2019 (the "IPO" ) or between February 8, 2019 and December 13, 2019, inc
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
06:20pm, Monday, 25'th May 2020
NEW YORK, NY / ACCESSWIRE / May 25, 2020 / Pomerantz LLP is investigating claims on behalf of investors Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ:GOSS). Such investors ...
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DOYU, GOSS and BBBY
10:20am, Monday, 25'th May 2020
NEW YORK, NY / ACCESSWIRE / May 25, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participa
Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering in February 2019 (the "IPO" ) or between February 8, 2019 and December 13, 2019, inc
LAWSUITS FILED AGAINST GOSS, LBRT and BIDU - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
06:35pm, Sunday, 24'th May 2020
NEW YORK, NY / ACCESSWIRE / May 24, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
12:00am, Sunday, 24'th May 2020
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Surface Oncology Inc (...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
12:50pm, Saturday, 23'rd May 2020
NEW YORK, NY / ACCESSWIRE / May 23, 2020 / Pomerantz LLP is investigating claims on behalf of investors Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ:GOSS). Such investors ...
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ANAB, GOSS and HALL
09:45pm, Friday, 22'nd May 2020
NEW YORK, NY / ACCESSWIRE / May 22, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participa
Shareholder Alert: Robbins LLP Announces Gossamer Bio, Inc. (GOSS) Sued for Misleading Shareholders
08:18pm, Friday, 22'nd May 2020
Shareholder rights law firm Robbins LLP announces that a purchaser of Gossamer Bio, Inc. (NASDAQ: GOSS) filed a class action complaint against the Company for alleged violations of the Securities Exch
New York, New York--(Newsfile Corp. - May 22, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Gossamer Bio, Inc. (NASDAQ: GOSS) alleging
LOS ANGELES, CA / ACCESSWIRE / May 22, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Gossamer Bio, Inc. ("Gossamer"
New York, New York--(Newsfile Corp. - May 21, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of G
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. – GOSS
08:59pm, Thursday, 21'st May 2020
Pomerantz LLP is investigating claims on behalf of investors Gossamer Bio, Inc. (“Gossamer” or the “Company”) (GOSS). Such investors are advised to contact Robert S. Willoughby at rswilloughb
